You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tumor Regression

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oncological Impact of Lateral Nodes in Rectal Cancer

Completed
  • Colorectal Adenocarcinoma
  • Neoadjuvant chemoradiotherapy (CRT)
  • (no location specified)
Oct 20, 2022

DLCS for Predicting Neoadjuvant Chemotherapy Response

Recruiting
  • Gastric Cancer
  • +4 more
  • develop and visualized a radio-clinical signatures from pretreatment oversampled CT images
  • Hangzhou, Zhejiang, China
    Cancer Hospital of the University of Chinese Academy of Sciences
Nov 8, 2022

Gastric Cancer, Adenocarcinoma of the Stomach Trial in Roma (CT scan)

Recruiting
  • Gastric Cancer
  • Adenocarcinoma of the Stomach
  • CT scan
  • Roma, Italy
    Giovanni Maria Garbarino
May 6, 2021

Predict Tumor Regression Grading in Locally Advanced Rectal

Unknown status
  • Rectal Cancer
    • Guangzhou, Guangdong, China
    • +2 more
    Feb 15, 2020

    Advanced Melanoma Trial in Boston (pembrolizumab)

    Terminated
    Has Results
    • Advanced Melanoma
    • pembrolizumab
    • Boston, Massachusetts
    • +1 more
    Jun 29, 2020

    gastRic Cancer patIentS Undergoing Multimodal trEatment

    Recruiting
    • Gastric Cancer
    • +3 more
    • Observational Survey
    • Lublin, Poland
      Medical University of Lublin
    Feb 9, 2023

    Low Rectal Cancer Trial in Hanzhou (Modified short-course radiotherapy, PD-1 antibody, Capecitabine)

    Not yet recruiting
    • Low Rectal Cancer
    • Modified short-course radiotherapy
    • +3 more
    • Hanzhou, Zhejiang, China
      Sir Run Run Shao hospital
    Jul 31, 2023

    Colon Tumor Trial in Hangzhou (Oxaliplatin, Capecitabine, Anti-PD-L1 Monoclonal Antibody)

    Not yet recruiting
    • Colon Neoplasm
    • Hangzhou, Zhejiang, China
      Second Affiliated Hospital of Zhejiang University School of Medi
    Jun 25, 2023

    Liver Metastases Trial (Diffusing Alpha Radiation Emitters Therapy (DaRT))

    Not yet recruiting
    • Liver Metastases
    • Diffusing Alpha Radiation Emitters Therapy (DaRT)
    • (no location specified)
    Apr 23, 2023

    CIN3, Cervical Intraepithelial Neoplasia, Cervical Intraepithelial Neoplasia Grade 3 Trial in Groningen (Vvax001 therapeutic

    Recruiting
    • CIN3
    • +3 more
    • Vvax001 therapeutic cancer vaccine
    • Groningen, Netherlands
      University Medical Center Groningen (UMCG)
    Aug 23, 2023

    Evaluation of Inflammatory Markers in LARC Patients

    Completed
    • Locally Advanced Rectal Cancer
    • Inflammatory markers
    • (no location specified)
    Jun 8, 2023

    Locally Advanced Rectal Cancer, Total Neoadjuvant Treatment, Anti-PD-1 Trial in Changchun (nCRT ? (CapeOX+Sintilimab)×6 ?

    Not yet recruiting
    • Locally Advanced Rectal Cancer
    • +2 more
    • nCRT → (CapeOX+Sintilimab)×6 → Surgery/W&W
    • Changchun, Ji Lin, China
      First Hospital of Jilin University
    Aug 11, 2023

    Different Ultrasound Methods for Discrimination Between Benign

    Unknown status
    • Patients With Adnexal Mass Prior to Surgery
    • Standardized transvaginal ultrasound examination
    • Leuven, Belgium
      University Hospitals Leuven
    Apr 12, 2020

    pTRG in Rectal Cancer With Establishment of

    Recruiting
    • Rectal Cancer
    • pelvic MRI for establishing new mrTRG method
    • Beijing, Beijing, China
    • +2 more
    May 11, 2022

    Rectal Cancer Trial (Chemoradiation treatment, 18FDG-PET/MRI scan)

    Not yet recruiting
    • Rectal Cancer
    • Chemoradiation treatment
    • 18FDG-PET/MRI scan
    • (no location specified)
    Sep 26, 2023

    Low-grade Oral Dysplasia Trial in Boston (Probiotic oral lozenges, Standard of care for oral dysplasia)

    Not yet recruiting
    • Low-grade Oral Dysplasia
    • Probiotic oral lozenges
    • Standard of care for oral dysplasia
    • Boston, Massachusetts
      Boston Medical Center
    Jan 22, 2023

    Breast Cancer Trial in Edmonton (Short-term diet and exercise intervention)

    Enrolling by invitation
    • Breast Cancer
    • Short-term diet and exercise intervention
    • Edmonton, Alberta, Canada
      University of Alberta
    Jan 4, 2023

    Colorectal Tumors Trial in New York (Botensilimab, Balstilimab)

    Not yet recruiting
    • Colorectal Neoplasms
    • New York, New York
      Weill Cornell Medicine/NewYork-Presbyterian Hospital
    Jan 24, 2023

    New Prognostic Index for Neoadjuvant Chemotherapy Outcome in

    Enrolling by invitation
    • Ovarian Cancer
    • +2 more
    • CRS scoring
    • Routine blood laboratory testing before treatment
    • Guangzhou, Guangdong, China
      The Sun Yat-sen Memorial Hospital of Sun Yat-sen University
    Nov 2, 2023

    Cervical Cancer, Online Adaptative Radiation Therapy, MRI Trial in Avignon (Magnetic resonance imaging)

    Recruiting
    • Cervical Cancer
    • +2 more
    • Magnetic resonance imaging
    • Avignon, France
      Institut Sainte Catherine
    Jun 8, 2023

    GIST Trial in Xi'an (Imatinib)

    Recruiting
    • GIST
    • Xi'an, Shaanxi, China
      Xijing Hospital of Air Force Military Medical University
    Jun 8, 2023

    Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage II Gastroesophageal Junction

    Not yet recruiting
    • Clinical Stage I Gastric Cancer AJCC v8
    • +9 more
    • Atezolizumab
    • +12 more
    • (no location specified)
    Apr 26, 2023

    Hypopharyngeal Cancer Trial (Cisplatin/Nedaplatin, albumin paclitaxel)

    Not yet recruiting
    • Hypopharyngeal Cancer
    • Cisplatin/Nedaplatin, albumin paclitaxel
    • (no location specified)
    May 5, 2023

    Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles

    Active, not recruiting
    • Mucinous Adenocarcinoma of the Rectum
    • +7 more
    • bevacizumab
    • +4 more
    • Los Angeles, California
      USC Norris Comprehensive Cancer Center
    Aug 5, 2022

    Rectal Tumors Trial in Cleveland (Pembrolizumab, External beam radiation, Capecitabine)

    Recruiting
    • Rectal Neoplasms
    • Cleveland, Ohio
      Cleveland Clinic, Case Comprehensive Cancer Center
    Jan 25, 2023